MarketsSensex Drops 600 Pts, Nifty Slips Below 24,850: 3 Reasons Behind Tuesday’s Market FallBY Harshita Dudeja
ExplainersSubscriber Exodus Pushes Tata Play’s FY25 Loss to Rs 510 Cr—Can It Stage a Comeback?BY Vikash Tripathi
ExplainersFrom Slump to Surge: Why the Market That Fell Isn’t the One That Bounced BackBY Vaibhavi Ranjan
Economy & PolicyTrump's 'Gold Card' Coming In A Week: America Wants Rich, But Loses Its Own | $5Mn Visa Paradox ExplainedBY Devabrata Dutta
MarketsGlobal Bond Markets Slip Into a Tailspin, but Could This Be India’s Moment to Shine?BY Vaibhavi Ranjan
ExplainersHow IndusInd’s Accounting ‘Discrepancies’ Turned into an Alleged ‘Fraud’ – A TimelineBY Vikash Tripathi
MarketsDéjà Vu on D-Street: Is the Indian Market Swaying to the Tune of Narrative-Driven Euphoria Again?BY Vaibhavi Ranjan
MarketsWhy Is the Stock Market Down Today? Sensex, Nifty Slide as Global Sentiment Worsens, Investors Book ProfitsBY Vaibhavi Ranjan
MarketsRiding the Rally: As Markets Soar on Optimism, Analysts Suggest Eyeing for ‘Buy-On-Dips’ BetsBY Vaibhavi Ranjan
ExplainersDefence Stocks Swell Up Rs 4.28 Lakh Crore in M-cap Since Feb; Is it Time to Reap Some Profits?BY Aman Aryan
MarketsIndian Defence Stocks Fire Up After Indo-Pak Conflict Fell Silent, China's Lag Behind - Tale of Two MarketsBY Harshita Dudeja
ExplainersDefence Stocks Are Buzzing Again, Is It a Comeback Story Worth Betting On?BY Vaibhavi Ranjan
MarketsNew Product Launches Save the Day for Dr Reddy’s in Q4, But Margins Remain a Sour PillBY Harshita Dudeja
ExplainersTelcos Bank on Rural India to Drive Growth, but Tariff Hikes Slow User AdditionBY Vikash Tripathi
MarketsTrump Inks Order to Bring Down US Drug Prices, But Skips Details on Generics DrugsBY Vaibhavi Ranjan
IndustryWill Climate Finance Taxonomy Help India Unlock $2.5 Trillion in Green Investment?BY Nandini Keshari
MarketsYes Bank Crisis to Resolve? Here's Everything You Need to Know as Sumitomo Steps InBY Harshita Dudeja
